Drug regulation in India

Govt approves 50% price rise for 8 essential drugs after manufacturers say production is ‘unviable’

New Delhi: India’s apex drug pricing regulator Monday allowed a 50 percent rise in the prices of 8 essential drugs used by people with asthma, glaucoma, thalassemia, tuberculosis, and mental health …

Drug regulator gives conditional nod for sale of 5 FDCs, seeks efficacy & safety data for 3 of them

by Margaret Jenner

New Delhi: India’s apex drug regulator has given conditional approval to continue the manufacture and sale of five fixed-dose combination (FDC) medicines, asking drugmakers to produce post-marketing safety and efficacy data …